iQur Ltd


iQur is at the forefront of vaccine research and development, using tandem core technology to create novel vaccines, currently being developed for influenza, malaria, human cytomegalovirus, dengue fever and hepatitis C.

At iQur, they are designing vaccines to provide protection against major global health challenges. They are targeting several different viruses using their patented proprietary technology and hope to bring benefit to people around the world by protecting them against a range of major pathogens.